HealthMore in Health→
Gut Microbiome Transplants Boost Cancer Immunotherapy Results
Key Takeaways
- Melanoma patients receiving microbiome transplants had 42% immunotherapy response rate vs 27% control
- Results consistent across three independent trials with different cancer types
- Could become standard adjunct to immunotherapy if confirmed in phase three trials
DE
DT Editorial Team··4 min read·via nature.com